Noteworthy Work
K&L Gates Advises Axonics on $138 Million IPO
21 November 2018
Orange County - Global law firm K&L Gates LLP has advised medical technology company Axonics Modulation Technologies, Inc. on its successful initial public offering of 9.2 million shares of common stock, raising $138 million in gross proceeds before underwriting discounts, commissions, and offering expenses.
Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018.
The K&L Gates team that advised Axonics was led by Orange County managing partner Michael Hedge. Other key team members from K&L Gates include food, drugs, medical devices and cosmetics partner Michael Hinckle, employee benefits partner Matthew Jones, and corporate associates Jason Dreibelbis, Alexa Ekman, and Hillary O’Rourke.
Axonics’ common stock began trading on The Nasdaq Global Select Market under the ticker symbol “AXNX” on October 31, 2018.
The K&L Gates team that advised Axonics was led by Orange County managing partner Michael Hedge. Other key team members from K&L Gates include food, drugs, medical devices and cosmetics partner Michael Hinckle, employee benefits partner Matthew Jones, and corporate associates Jason Dreibelbis, Alexa Ekman, and Hillary O’Rourke.
K&L Gates is a fully integrated global law firm with lawyers located across five continents. The firm represents leading multinational corporations, growth and middle-market companies, capital markets participants and entrepreneurs in every major industry group as well as public sector entities, educational institutions, philanthropic organizations and individuals.
